STRONG RESULTS FOR NAO.VNS™ FIRST-IN-HUMAN STUDY

Synergia Medical aims to advance neuromodulation with optoelectronic technology offering:

Full MRI compatibility – Designed to allow low-restriction MRI scans (100–150M annually worldwide), potentially reducing patient care limitations and burdens. Real-time activity during imaging is intended to enable physicians to adjust therapy while observing brain responses—an approach that may help enhance VNS efficacy.

EMI immunity – Developed to provide protection against widely used medical EMI sources such as electrosurgery (utilized in 80% of surgeries) and defibrillators, with the goal of ensuring greater safety in patient care.

Extended battery life & fast recharging – Engineered to minimize EMI-related power inefficiencies, allowing for a rapid recharge (around 1 minute daily) for an expected long-term battery lifetime of 15 years. This could reduce replacement surgeries and may support energy-intensive stimulation modes potentially enhancing therapy.

Enhanced cybersecurity – Intended to reduce exposure to external and remote hacking through closed-loop optical communication, providing a potentially more secure system.

Synergia’s technology is an investigational device, not approved for commercial use. Any information contained herein is preliminary, based on limited internal data and should not be construed as safety or performance claims. This is not an offer to sell or a solicitation to buy.